Archives
-
ApexPrep DNA Plasmid Miniprep Kit for AML
2026-09-16
Build cleaner cloning, sequencing, and expression workflows around reproducible plasmid preparation. The ApexPrep DNA Plasmid Miniprep Kit connects high-purity DNA recovery with AML studies involving LMO2/LDB1 perturbation, rescue experiments, and orthogonal molecular assays.
-
Hoechst 33342 Nuclear Stain for Senescence Workflows
2026-09-16
Hoechst 33342 is a cell-permeant DNA-binding dye for live and fixed cell nuclear staining. The K2407 1 mg/mL solution supports fluorescence microscopy and flow cytometry workflows, but nuclear labeling should not be interpreted as an independent senescence or mitochondrial-quality marker.
-
Cy7 NHS ester: Practical Labeling Guide
2026-09-15
Cy7 NHS ester (SKU A8109) is a water-soluble amino-reactive near-infrared dye for labeling proteins, peptides, and other biomolecules without requiring an organic co-solvent. This guide covers conjugation setup, purification, optical QC, and limitations; it should not be treated as evidence of validated uptake, toxicity, or biodistribution in every live-cell or in vivo model.
-
Anti-ROR1 Antibody: Applied Workflows
2026-09-15
Translate ROR1 binding into reproducible ELISA, FACS, signaling, and model-based experiments with Zilovertamab. This workflow also shows how ROR1 measurements can complement, but not replace, established assays in deoxynivalenol liver-injury research.
-
PVT1–HIF-1α Feedback in Pancreatic Cancer
2026-09-14
The reference study identifies a positive feedback loop in which the lncRNA PVT1 promotes HIF-1α transcription and stabilizes HIF-1α protein, while HIF-1α also supports PVT1 expression. This two-level regulatory model links hypoxic adaptation with pancreatic cancer progression and provides a mechanistic framework for transcriptional and protein-stability experiments.
-
NleE–ZPR1 Phase Separation and Host UPRER
2026-09-14
The Cell Reports study identifies ZPR1 as a transient interaction partner of the EPEC effector NleE and connects ZPR1 liquid–liquid phase separation with transcriptional control of the endoplasmic reticulum unfolded protein response. Its combination of proximity-enabled protein crosslinking, biochemical phase-separation analysis, and infection-pathway validation provides a mechanistic framework for understanding how bacterial effectors suppress host defense.
-
Ginsenoside Rg1: Neuroimmune Research Workflow
2026-09-13
Build a reproducible Ginsenoside Rg1 workflow around anesthesia-induced gut–immune–brain disruption, with practical controls for solubility, dosing, behavioral testing, and Treg-dependent mechanism validation. The approach also shows how this triterpene saponin can support neuroprotection research while keeping exploratory apoptosis and inflammation endpoints scientifically separated from validated findings.
-
Magnetic CAR-T-Mimicking Cells In Vivo
2026-09-12
The reference study presents a magnetic bispecific nano-antibody that recruits endogenous T cells, activates them through CD3 engagement, and directs them toward PDL1-positive solid tumors with an external magnetic field. This non-genetic, spatially controlled strategy addresses major barriers in solid-tumor CAR-T therapy, particularly inefficient tumor infiltration and immunosuppressive microenvironments.
-
Marein Restores Mitoxantrone Sensitivity via ABCG2
2026-09-11
A 2024 Biochemical Pharmacology study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug-efflux transporter. By increasing intracellular exposure to ABCG2 substrates including Mitoxantrone, marein restored chemosensitivity in resistant cancer-cell models and linked this activity to the conserved F439 residue.
-
Amyloid β-Peptide (1-42): Lab Guide
2026-09-11
A practical, scenario-based guide to using Amyloid β-Peptide (1-42) (human), SKU B6057, in neuronal viability and microglial response studies. It connects peptide handling, aggregation state, controls, and interpretation to published Aβ42 biology and routine assay decisions.
-
SFRP1, Wnt/β-Catenin, and Oral Fibrosis
2026-09-10
The reference study identifies reduced SFRP1 expression as a feature of arecoline-induced oral submucous fibrosis and connects this change with neutrophil infiltration and Wnt/β-catenin pathway activity. Its combination of tissue correlation, SFRP1 overexpression, and pathway-activator rescue provides a useful framework for separating inflammatory and fibrotic components of OSF biology.
-
Actinomycin D for Hypoxia–m6A RNA Studies
2026-09-10
Actinomycin D (ActD) can turn the YTHDF1–THBS1 hypoxia pathway into a time-resolved mRNA stability question. This guide pairs the 2023 osteogenesis study with assay design, controls, handling, and interpretation that distinguish RNA decay from transcriptional stress and apoptosis induction.
-
Rocilinostat (ACY-1215): HDAC6 Translation
2026-09-09
Rocilinostat (ACY-1215) offers a selective way to connect HDAC6 engagement with α-tubulin acetylation, multiple myeloma biology, and proteasome-inhibitor combinations. In parallel, SMPD4 research provides a valuable cross-domain reminder: cilia and developmental phenotypes require mechanistic validation rather than simple target extrapolation.
-
4-Hydroxytamoxifen B6167: DMSO Workflow Guide
2026-09-09
4-Hydroxytamoxifen B6167 provides a DMSO-compatible estrogen receptor modulator for controlled cell, cardiac myocyte, and selected mouse-model workflows. It should not be selected for protocols requiring aqueous or ethanol-based preparation, and prepared solutions should not be stored long term.
-
Ginsenoside Rg1: Neuroimmune Research Workflow
2026-09-08
Build a translationally relevant workflow around Ginsenoside Rg1 by connecting behavior, cytokines, synaptic function, gut-barrier integrity, and regulatory T cells in one experimental design. The approach is especially useful for anesthesia-related neuroimmune disruption, while offering practical extensions for neuroprotection research and inflammation-focused assays.